- Home
- CRVO vs NPT Comparison
CRVO vs NPT Comparison
Compare CRVO & NPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVO | NPT |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.9M | 39.0M |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRVO | NPT |
|---|---|---|
| Price | $2.87 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 46.7K | ★ 404.8K |
| Earning Date | 05-12-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,006,510.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.89 | $1.14 |
| 52 Week High | $13.13 | $22.38 |
Technical Indicators
Market Signals| Indicator | CRVO | NPT |
|---|---|---|
| Relative Strength Index (RSI) | 23.54 | 34.76 |
| Support Level | N/A | $1.25 |
| Resistance Level | $4.27 | $5.96 |
| Average True Range (ATR) | 0.24 | 0.17 |
| MACD | -0.08 | 0.24 |
| Stochastic Oscillator | 2.62 | 20.00 |
Price Performance
Historical ComparisonAbout CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About NPT Texxon Holding Limited Ordinary shares
Texxon Holding Ltd provides technology-enabled supply chain management services to customers in the plastics and chemical industries in East China. The company operates through two segments: Supply Chain Trading and Plastic Manufacturing. Its services include procurement, logistics, payments, and fulfillment for Chinese SMEs, and all revenue is generated from operations within the People's Republic of China.